These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

853 related articles for article (PubMed ID: 28601837)

  • 21. Developing a core outcome set on traditional Chinese medicine (COS-TCM) for chronic heart failure (CHF): a study protocol.
    Zhang M; Chua HZ; Zhang J; Niu B; Zheng W; Li K; Zhang B
    BMJ Open; 2021 Jul; 11(7):e047148. PubMed ID: 34215606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a Core outcome set for fetal Myelomeningocele (COSMiC): study protocol.
    Altoukhi S; Whitehead CL; Ryan G; Deprest J; Joyeux L; Gallagher K; Drake J; Church P; Horn D; Diambomba Y; Carvalho JCA; Van Mieghem T
    Trials; 2020 Aug; 21(1):732. PubMed ID: 32825852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study protocol: developing, disseminating, and implementing a core outcome set for selective fetal growth restriction in monochorionic twin pregnancies.
    Khalil A; Duffy JMN; Perry H; Ganzevoort W; Reed K; Baschat AA; Deprest J; Gratacos E; Hecher K; Lewi L; Lopriore E; Oepkes D; Papageorghiou A; Gordijn SJ;
    Trials; 2019 Jan; 20(1):35. PubMed ID: 30626413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardised Outcomes in Nephrology-Children and Adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney disease.
    Tong A; Samuel S; Zappitelli M; Dart A; Furth S; Eddy A; Groothoff J; Webb NJ; Yap HK; Bockenhauer D; Sinha A; Alexander SI; Goldstein SL; Gipson DS; Hanson CS; Evangelidis N; Crowe S; Harris T; Hemmelgarn BR; Manns B; Gill J; Tugwell P; Van Biesen W; Wheeler DC; Winkelmayer WC; Craig JC;
    Trials; 2016 Aug; 17():401. PubMed ID: 27519274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease.
    Cho Y; Sautenet B; Rangan G; Craig JC; Ong ACM; Chapman A; Ahn C; Chen D; Coolican H; Kao JT; Gansevoort R; Perrone R; Harris T; Torres V; Pei Y; Kerr PG; Ryan J; Gutman T; Howell M; Ju A; Manera KE; Teixeira-Pinto A; Hamiwka LA; Tong A
    Trials; 2017 Nov; 18(1):560. PubMed ID: 29169385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A core outcomes set for clinical trials of interventions for young adults with type 1 diabetes: an international, multi-perspective Delphi consensus study.
    Byrne M; O'Connell A; Egan AM; Dinneen SF; Hynes L; O'Hara MC; Holt RIG; Willaing I; Vallis M; Hendrieckx C; Coyne I
    Trials; 2017 Dec; 18(1):602. PubMed ID: 29258565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Creation of a core outcome set for clinical trials of people with shoulder pain: a study protocol.
    Gagnier JJ; Page MJ; Huang H; Verhagen AP; Buchbinder R
    Trials; 2017 Jul; 18(1):336. PubMed ID: 28728574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COSUTI: a protocol for the development of a core outcome set (COS) for interventions for the treatment of uncomplicated urinary tract infection (UTI) in adults.
    Duane S; Vellinga A; Murphy AW; Cormican M; Smyth A; Healy P; Moore M; Little P; Devane D
    Trials; 2019 Feb; 20(1):106. PubMed ID: 30732617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Core outcome set for studies on pregnant women with vasa previa (COVasP): a study protocol.
    D'Souza R; Villani L; Hall C; Seyoum M; Kingdom J; Krznaric M; Donnolley N; Javid N
    BMJ Open; 2020 Jul; 10(7):e034018. PubMed ID: 32690497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a core outcome set and identification of patient-reportable outcomes for primary brain tumour trials: protocol for the COBra study.
    Retzer A; Sivell S; Scott H; Nelson A; Bulbeck H; Seddon K; Grant R; Adams R; Watts C; Aiyegbusi OL; Kearns P; Cruz Rivera S; Dirven L; Baddeley E; Calvert M; Byrne A
    BMJ Open; 2022 Sep; 12(9):e057712. PubMed ID: 36180121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an international core outcome set for treatment trials in necrotizing enterocolitis-a study protocol.
    Klerk DH; van Varsseveld OC; Offringa M; Modi N; Lacher M; Zani A; Pakarinen MP; Koivusalo A; Jester I; Spruce M; Derikx JPM; Bakx R; Ksia A; Vermeulen MJ; Kooi EMW; Hulscher JBF
    Trials; 2023 May; 24(1):367. PubMed ID: 37259112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes.
    Thorlacius L; Ingram JR; Garg A; Villumsen B; Esmann S; Kirby JS; Gottlieb AB; Merola JF; Dellavalle R; Christensen R; Jemec GB
    BMJ Open; 2017 Feb; 7(2):e014733. PubMed ID: 28219961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute severe paediatric asthma: study protocol for the development of a core outcome set, a Pediatric Emergency Reserarch Networks (PERN) study.
    Craig S; Babl FE; Dalziel SR; Gray C; Powell C; Al Ansari K; Lyttle MD; Roland D; Benito J; Velasco R; Hoeffe J; Moldovan D; Thompson G; Schuh S; Zorc JJ; Kwok M; Mahajan P; Johnson MD; Sapien R; Khanna K; Rino P; Prego J; Yock A; Fernandes RM; Santhanam I; Cheema B; Ong G; Chong SL; Graudins A;
    Trials; 2020 Jan; 21(1):72. PubMed ID: 31931862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment.
    Tallouzi MO; Mathers JM; Moore DJ; Bucknall N; Calvert MJ; Murray PI; Denniston AK;
    Ophthalmology; 2021 Aug; 128(8):1209-1221. PubMed ID: 33515595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a core outcome set for diabetes after pregnancy prevention interventions (COS-DAP): a study protocol.
    Nielsen KK; O'Reilly S; Wu N; Dasgupta K; Maindal HT
    Trials; 2018 Dec; 19(1):708. PubMed ID: 30594221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of interventions for informed consent for randomised controlled trials (ELICIT): protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Gillies K; Entwistle V; Treweek SP; Fraser C; Williamson PR; Campbell MK
    Trials; 2015 Oct; 16():484. PubMed ID: 26507504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of an international core outcome set for treatment trials in paediatric inguinal hernia: protocol for a three-phase study including a systematic review and Delphi survey.
    Maat SC; Gorter RR; van Heurn ELW; Rippen H; Butcher NJ; Offringa M; Derikx JPM
    BMJ Open; 2023 Dec; 13(12):e077452. PubMed ID: 38097238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials.
    Callis Duffin K; Merola JF; Christensen R; Latella J; Garg A; Gottlieb AB; Armstrong AW
    JAMA Dermatol; 2018 Oct; 154(10):1137-1144. PubMed ID: 29874367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardised outcomes in nephrology - Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis.
    Tong A; Manns B; Hemmelgarn B; Wheeler DC; Tugwell P; Winkelmayer WC; van Biesen W; Crowe S; Kerr PG; Polkinghorne KR; Howard K; Pollock C; Hawley CM; Johnson DW; McDonald SP; Gallagher MP; Urquhart-Secord R; Craig JC;
    Trials; 2015 Aug; 16():364. PubMed ID: 26285819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A protocol for developing, disseminating, and implementing a core outcome set for pre-eclampsia.
    Duffy JM; van 't Hooft J; Gale C; Brown M; Grobman W; Fitzpatrick R; Karumanchi SA; Lucas N; Magee L; Mol B; Stark M; Thangaratinam S; Wilson M; von Dadelszen P; Williamson P; Khan KS; Ziebland S; McManus RJ;
    Pregnancy Hypertens; 2016 Oct; 6(4):274-278. PubMed ID: 27939467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.